IL105270A - Parental solutions containing 3-dialkylaminoatoxybenzoyl-benzopurans - Google Patents

Parental solutions containing 3-dialkylaminoatoxybenzoyl-benzopurans

Info

Publication number
IL105270A
IL105270A IL10527093A IL10527093A IL105270A IL 105270 A IL105270 A IL 105270A IL 10527093 A IL10527093 A IL 10527093A IL 10527093 A IL10527093 A IL 10527093A IL 105270 A IL105270 A IL 105270A
Authority
IL
Israel
Prior art keywords
amiodarone
solution
acetate buffer
acetate
concentration
Prior art date
Application number
IL10527093A
Other languages
English (en)
Hebrew (he)
Other versions
IL105270A0 (en
Original Assignee
Academic Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academic Pharmaceuticals filed Critical Academic Pharmaceuticals
Publication of IL105270A0 publication Critical patent/IL105270A0/xx
Publication of IL105270A publication Critical patent/IL105270A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
IL10527093A 1992-04-01 1993-04-01 Parental solutions containing 3-dialkylaminoatoxybenzoyl-benzopurans IL105270A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/861,608 US5234949A (en) 1992-04-01 1992-04-01 Parenteral solutions containing amiodarone in acetate buffer solution

Publications (2)

Publication Number Publication Date
IL105270A0 IL105270A0 (en) 1993-08-18
IL105270A true IL105270A (en) 1999-11-30

Family

ID=25336272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10527093A IL105270A (en) 1992-04-01 1993-04-01 Parental solutions containing 3-dialkylaminoatoxybenzoyl-benzopurans

Country Status (10)

Country Link
US (1) US5234949A (de)
EP (1) EP0633777B1 (de)
JP (1) JP3253302B2 (de)
AT (1) ATE172115T1 (de)
AU (1) AU3969593A (de)
CA (1) CA2133324C (de)
DE (1) DE69321585T2 (de)
IL (1) IL105270A (de)
WO (1) WO1993019753A1 (de)
ZA (1) ZA932304B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735978B1 (fr) * 1995-06-30 1997-09-19 Sanofi Sa Composition pharmaceutique d'amiodarone pour administration parenterale
US6030998A (en) * 1997-06-27 2000-02-29 Academic Pharmaceuticals, Lp Methods for treating arrhythmia using acetate buffer solutions of amiodarone
US5981514A (en) * 1998-02-12 1999-11-09 Somberg; John C. (N-alkyl-N-hydroxymethylamino)alkoxybenzoylbenzofurans and the phosphate esters thereof
US6479541B1 (en) 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration
US20020143051A1 (en) 2001-03-29 2002-10-03 Doty Mark J. Premixed amiodarone parenteral solution and method for making the same
ATE386512T1 (de) * 2001-03-29 2008-03-15 Baxter Int Vorgemischte amiodaron-haltige parenterale lösung und deren herstellungsverfahren
US6869939B2 (en) * 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
US20090270496A1 (en) * 2007-05-03 2009-10-29 Courchesne William E Antifungal compounds
EP2335686A1 (de) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. Wässrige intravenöse Nanosuspension mit minimalen Nebenwirkungen
MX2012014479A (es) 2010-06-11 2013-05-20 Baxter Int Formulaciones que incluyen amiodarona y sales de la misma y metodos para su fabricacion y uso.
US9642828B2 (en) 2014-09-23 2017-05-09 Sun Pharmaceutical Industries Limited Parenteral dosage form of amiodarone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
FR2550091B1 (fr) * 1983-08-02 1986-05-23 Sanofi Sa Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
JP2957618B2 (ja) * 1989-02-20 1999-10-06 バリガドゥー，ソーリアナレン アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物

Also Published As

Publication number Publication date
IL105270A0 (en) 1993-08-18
EP0633777B1 (de) 1998-10-14
CA2133324A1 (en) 1993-10-14
JPH08500330A (ja) 1996-01-16
EP0633777A1 (de) 1995-01-18
WO1993019753A1 (en) 1993-10-14
ATE172115T1 (de) 1998-10-15
DE69321585T2 (de) 1999-03-04
CA2133324C (en) 2005-02-01
DE69321585D1 (de) 1998-11-19
JP3253302B2 (ja) 2002-02-04
AU3969593A (en) 1993-11-08
ZA932304B (en) 1994-09-15
US5234949A (en) 1993-08-10

Similar Documents

Publication Publication Date Title
US3773939A (en) N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
EP0633777B1 (de) PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE
CN102665713A (zh) 治疗心房颤动的方法
RU2213560C2 (ru) Фармацевтическая композиция, содержащая сочетание правовращающего и левовращающего изомеров соталола
EP1006793B1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
US9125877B2 (en) Use of kauranes compounds in the manufacture of medicament
US8664267B2 (en) Parenteral solution containing amiodarone in NNDMA (N,N,-Dimethylacetamide)
US6410601B2 (en) Histochrome and its therapeutic use in acute myocardial infarction and ischemic heart disease
US4320110A (en) Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats
US6103757A (en) Methods for treating arrhythmia using acetate buffer solutions of amiodarone
US4713370A (en) Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats
JP2957618B2 (ja) アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物
Frishman et al. Ultra-short-acting β-adrenergic blockers
JPH04338328A (ja) 血管形成阻害剤として有用なベンゾイルカルビノール及びそのエステル
RU2358732C2 (ru) Жидкие фармацевтические композиции, содержащие производные 3,7-диазабицикло(3,3,1)нонана, для лечения антиаритмических реакций
US4259342A (en) Antianginal treatment with azepine derivatives
HU204700B (en) Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives
US4495201A (en) Pharmaceutical composition and method for treating heart diseases therewith
Polgar et al. Cardiac electrophysiologic effects of adaprolol maleate, a new β-blocker, in closed chest dogs
JP6117918B2 (ja) デスエチルアミオダロン組成物
US20230172883A1 (en) Anti-arrhythmic compositions and methods
JPH0539226A (ja) サイトメガロウイルス感染症用薬剤
US20020045669A1 (en) Anti-arrhythmic composition and methods of treatment
HU212502B (en) Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydrothiopyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries
HU198622B (en) Process for producing stable, injectable, antemetic composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force